* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Friday, June 27, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

    Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

    Frontdoor Announces Tech Expert Dr. Bala Ganesh as Chief Technology Officer – Business Wire

    Frontdoor Appoints Tech Visionary Dr. Bala Ganesh as New Chief Technology Officer

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    China’s Military Introduces Mosquito-Sized Drones: A Game-Changing Surveillance Technology – Indian Defence Review

    China Unveils Mosquito-Sized Drones: Revolutionizing Surveillance Technology

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

    Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

    Frontdoor Announces Tech Expert Dr. Bala Ganesh as Chief Technology Officer – Business Wire

    Frontdoor Appoints Tech Visionary Dr. Bala Ganesh as New Chief Technology Officer

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    China’s Military Introduces Mosquito-Sized Drones: A Game-Changing Surveillance Technology – Indian Defence Review

    China Unveils Mosquito-Sized Drones: Revolutionizing Surveillance Technology

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma

September 30, 2023
in Health
IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma
Share on FacebookShare on Twitter

Use of intravenous immunoglobulin (IVIg) may substantially reduce the risk for severe infections in multiple myeloma patients treated with an anti-B-cell maturation antigen (BCMA) bispecific antibody, a small retrospective study suggested.

In 26 patients who achieved clinical responses to an anti-BCMA bispecific antibody, all experienced severe hypogammaglobulinemia, but during periods when patients were being treated with IVIg, the rate of grade 3-5 infections was reduced by 90% (incidence rate ratio 0.10, 95% CI 0.01-0.80, P=0.0307), reported researchers led by Guido Lancman, MD, MSc, of the University of Toronto.

These lower “infection rates during periods of immunoglobulin replacement is further evidence of the impact of severely impaired humoral immunity,” the team wrote in Blood Cancer Discovery. “Pending confirmation in other datasets and ideally in randomized prospective studies, these results provide a strong rationale for primary prophylaxis with IVIg or subcutaneous Ig in these patients.”

“To the best of our knowledge,” the authors said, “this is the first study to comprehensively analyze risk factors and mitigation strategies to prevent infections in myeloma patients receiving anti-BCMA bispecific antibodies.”

Results of the study “reinforce the need for vigilance and appropriate counseling of patients about infection risk with these potent immunotherapies,” observed Alfred L. Garfall, MD, and Edward A. Stadtmauer, MD, both of the University of Pennsylvania in Philadelphia, in an accompanying commentary. In particular, they suggested that the results support universal use of immunoglobulin replacement therapy in relapsed/refractory multiple myeloma patients receiving anti-BCMA bispecific antibody therapy.

Such a small study is not usually the basis for clinical practice recommendations, Garfall and Stadtmauer added, but “the results affirm the impressions of clinicians with experience using these agents in clinical trials as reflected in recent consensus statements that recommend universal use of [immunoglobulin replacement therapy] in these patients.”

Bispecific antibodies targeting BCMA have been increasingly used to treat multiple myeloma, with two — elranatamab (Elrexfio) and teclistamab (Tecvayli) — receiving FDA approval in this space.

However, while these therapies have achieved impressive efficacy in patients with heavily pretreated multiple myeloma, and are generally well tolerated, “infection has now emerged as an important toxicity,” Lancman and colleagues observed.

They noted that some previous research suggests that IVIg can be used to successfully reduce infection rates in multiple myeloma patients with hypogammaglobulinemia and non-progressive disease, as well as in multiple myeloma patients receiving the anti-CD38 monoclonal antibody daratumumab (Darzalex).

The retrospective study by Lancman and co-authors included 37 patients with heavily pretreated multiple myeloma who had received an anti-BCMA bispecific antibody. Median age was 66 years and 62% were female. The median time from initial diagnosis to treatment with the bispecific antibody was 7.4 years. Patients had a median of seven prior lines of therapy, about two-thirds had high-risk cytogenetics, 78% were triple-class refractory, and 24% were penta-drug refractory.

The overall response rate to the bispecific antibody was 70%. At a median follow-up time of 18.6 months, the median progression-free survival was 17.0 months and median overall survival was 26.3 months.

Of the 26 patients who responded to anti-BCMA bispecific antibody therapy and developed severe hypogammaglobulinemia (defined as IgG levels below 200 mg/dL), 92% received IVIg at some point during treatment.

There were a total of 118 infections during follow-up. Infections were most frequently reported in the respiratory tract (58%), followed by the urinary tract and skin (15% each). Most of the infections were either viral (46%) or bacterial (43%), with 11% fungal.

Twenty-six of the infections were grade 3-5 (0.7 per patient-year), and occurred in 15 patients. There were two grade 5 infections, which occurred at 15.1 months (COVID-19) and 17.6 months (sepsis).

Infections occurred in the first month in 27% of patients, including 14% with grade 3-5 infections. Six patients (16%) had co-occurrence of infection in the first month and cytokine release syndrome. The estimated median time to first any-grade infection was 3.8 months, and the estimated median time to first grade 3-5 infection was 18.7 months.

Lancman and colleagues acknowledged that the study was limited by its retrospective nature and relatively small size, as well as by the non-random administration of IVIg (delivered at the individual physician’s discretion).

author['full_name']

Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.

Disclosures

Lancman reported financial relationships with Janssen and Pfizer; co-authors reported multiple relationships with industry.

Garfall reported financial relationships with Janssen, Novartis, CRISPR Therapeutics, Tmunity Therapeutics, MBS, GSK, and Legend Bio; Stadtmauer reported financial relationships with Janssen, Takeda, BMS, AbbVie, and Amgen.

Primary Source

Blood Cancer Discovery

Source Reference: Lancman G, et al “IVIg use associated with ten-fold reduction of serious infections in multiple myeloma patients treated with anti-BCMA bispecific antibodies” Blood Cancer Discov 2023: DOI:10.1158/2643-3230.BCD-23-0049.

Secondary Source

Blood Cancer Discovery

Source Reference: Garfall A, Stadtmauer E “Understanding infection risk with anti-BCMA bispecific antibodies” Blood Cancer Discov 2023; DOI:10.1158/2643-3230.BCD-23-0157.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/hematologyoncology/myeloma/106567

Tags: healthImmunoglobulininfection
Previous Post

Future Motion Recalls Onewheel Self-Balancing Electric Skateboards Due to Crash Hazard; Four Deaths Reported

Next Post

Low Tidal Volume Compliance Still Lacking in Mechanical Ventilation

St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

June 27, 2025
NBA Draft 2025: Did the Hornets reach for Kon Knueppel? And why the Spurs did the right thing with Dylan Harper – Yahoo Sports

NBA Draft 2025: Did the Hornets Overreach for Kon Knueppel? Why the Spurs’ Pick of Dylan Harper Was a Brilliant Move

June 27, 2025
Fossil evidence of proboscidean frugivory and its lasting impact on South American ecosystems – Nature

Fossil evidence of proboscidean frugivory and its lasting impact on South American ecosystems – Nature

June 27, 2025
Distrust in public-health institutions is not just an American problem – The Economist

Distrust in public-health institutions is not just an American problem – The Economist

June 27, 2025
Cuts to federal science spending will cost every American – University of California

Cuts to federal science spending will cost every American – University of California

June 27, 2025
CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake – TCTMD.com

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake – TCTMD.com

June 27, 2025
TIFF announces first wave of World Premieres! – TIFF – Toronto International Film Festival

TIFF announces first wave of World Premieres! – TIFF – Toronto International Film Festival

June 27, 2025
With no end to war in sight, Ukraine’s economy teeters on the edge – The Washington Post

Ukraine’s Economy on the Edge as Conflict Shows No End in Sight

June 27, 2025
A typical workday for freelancer Ashley Abramson – Association of Health Care Journalists

A Day in the Life of Freelancer Ashley Abramson: Inside Her Dynamic Workday

June 27, 2025
‘This is not a luxury’: Families in Trump states agonize over GOP’s proposed Medicaid cuts – CNN

Families in Trump States Face Hardship Amid GOP’s Push for Major Medicaid Cuts

June 27, 2025

Categories

Archives

June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (699)
  • Economy (719)
  • Entertainment (21,613)
  • General (15,586)
  • Health (9,758)
  • Lifestyle (724)
  • News (22,149)
  • People (721)
  • Politics (726)
  • Science (15,937)
  • Sports (21,216)
  • Technology (15,704)
  • World (699)

Recent News

St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

June 27, 2025
NBA Draft 2025: Did the Hornets reach for Kon Knueppel? And why the Spurs did the right thing with Dylan Harper – Yahoo Sports

NBA Draft 2025: Did the Hornets Overreach for Kon Knueppel? Why the Spurs’ Pick of Dylan Harper Was a Brilliant Move

June 27, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version